Flagship Private Wealth’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Flagship Private Wealth’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-969	Closed	-$48.2K	–	158
2021 Q2	$48.2K	Buy	969 +923	+2,007%	+$43.3K	0.04%	135
2021 Q1	$2.13K	Sell	46 -923	-95%	-$45.1K	﹤0.01%	282
2020 Q4	$48.4K	Buy	+969	New	+$41.8K	0.05%	120

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RCS

Retirement Capital Strategies San Jose, California $265M AUM 11.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SHJ

Sharkey, Howes & Javer Denver, Colorado $829M AUM 20.38% 1-Year Est. Return

PWP

Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return

Flagship Private Wealth's IDNA Position: Q3 2021 in Review

Flagship Private Wealth sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2021, closing a stake of 969 shares — an estimated $48.2K sold.

Flagship Private Wealth first reported a position in IDNA in Q4 2020 and held it in 3 quarters. The position peaked at $48.4K in Q4 2020. 89 funds tracked by Wall St. Rank hold IDNA as of Q3 2021.

Flagship Private Wealth reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2021 after selling out during the quarter.
Flagship Private Wealth sold 969 iShares Genomics Immunology and Healthcare ETF shares in Q3 2021, an estimated $48.2K.
Flagship Private Wealth first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and held it in 3 quarters.
Flagship Private Wealth's iShares Genomics Immunology and Healthcare ETF position peaked at $48.4K in Q4 2020.
89 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2021.

Based on Flagship Private Wealth's 13F filing for Q3 2021, filed 20 Oct 2021.